About Biosynthesis
Biosynthesis was established in 1955 in Friendship, United States, within the pharmaceutical industry. Generic drugs are produced by the company to provide cost-effective alternatives to branded medications. Operations encompass formulation, synthesis, and quality control processes for various therapeutic categories. Distribution occurs primarily in domestic markets, with adherence to regulatory standards ensured throughout the supply chain. The domain biosintez.com supports online information access.
- Headquarter Friendship, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Sun Pharma
(Nov 23, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biosynthesis
Detailed funding history for Biosynthesis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biosynthesis
Biosynthesis has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sun Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
|
Locked | Locked | Locked |
Investor details for Biosynthesis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biosynthesis
Investment portfolio details for Biosynthesis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biosynthesis
Detailed financials for Biosynthesis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biosynthesis Comparisons
Peer comparison for Biosynthesis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biosynthesis
Detailed competitors of Biosynthesis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biosynthesis
Complete news archive for Biosynthesis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biosynthesis
Biosynthesis was founded in 1955.
Biosynthesis is headquartered in Friendship, United States.
Biosynthesis was established in 1955 in Friendship, United States, within the pharmaceutical industry. Generic drugs are produced by the company to provide cost-effective alternatives to branded medications. Operations encompass formulation, synthesis, and quality control processes for various therapeutic categories. Distribution occurs primarily in domestic markets, with adherence to regulatory standards ensured throughout the supply chain. The domain biosintez.com supports online information access.
Biosynthesis has 1 investor. Key investors include Sun Pharma.